Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CMS to discuss genetic tests for cancer

CMS released meeting material including an agenda and speaker list ahead of a May 1 meeting of its Medicare Evidence Development & Coverage Advisory Committee

Read the full 252 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE